|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Ulinastatin, an elastase in- hibitor, inhibits the increased mRNA expression of prostaglandin H2 synthase - type 2 in Kawasaki disease 显示文摘 | Zaitsu M Hamasaki Y Tashiro K | 2000 | J Infect Dis2000，181，3： | 1 |
| 2 | Leukotriene synthesis is increased by transcriptional up-regulation of 5-lipoxygenase, leukotriene A4 hydrolase, and leukotriene CA synthase in asthmatic children 显示文摘 | Zaitsu M Hamasaki Y Matsuo M lehimaru T Fujita I Ishii E | 2003 | J Asthma2003，40，2： | 1 |
| 3 | Ulinastatin,an elastase inhibits the mRNA expression of prostaglandin H2 synthase-type 2 in Kawasaki disease显示文摘 | Zaitsu M Hamasaki Y Tashiro K | 2000 | J Infect Dis2000，181，3： | 1 |
| 4 | Mapping of cerebral oxygen ex- traction fraction changes with susceptibility-weighted phase ima ging显示文摘 | Zaitsu Y Kudo K Terae S | 2011 | Radiology2011，261，3： | 1 |
| 5 | Mapping of cerebral oxygen ex-traction fraction changes with susceptibility-weighted phase im-aging显示文摘 | Zaitsu Y Kudo K Terae S | 2011 | Radiology2011，261，3： | 1 |
| 6 | Ulinastatin, an elastase inhibitor, inhibits the increased mRNA expression of prostaglandin H2 synthase-type 2 in Kawasaki disease显示文摘 | Hamasaki Y Tashiro K | 2000 | J Infect Dis2000，181，3： | 1 |
| 7 | Ulinastatin,an elastase inhibitor,inhibits the increased mRNA expression of prostaglandin H2 synthase-type 2 in kawasaki disease显示文摘 | Zaitsu M Hamasaki Y Tashiro K | 2000 | J Infect Dis2000，181，： | 1 |
| 8 | Ulinastatin, an elastase inhibitor, inhibits the inereased mRNA expression of prostaglandin H2 synthase-type 2 in Kawasaki disease 显示文摘 | Zaitsu M Hamasaki Y Tashiro K | 2000 | J Infect Dis2000，181，3： | 1 |
| 9 | Ulinastatin,an elastase inhibitor,inhibits the increased mRNA expression of prostaglandin H2 synthase-type 2 in Kawasaki disease显示文摘 | Zaitsu M Hamasaki Y Tashiro K | 2000 | J Infect Dis2000，181，3： | 1 |
| 10 | Ulinastatin,an elastase inhibitor, inhibits the increased mRNA expression of prostagland H2 synthase-type 2 in Kawasaki disease显示文摘 | Zaitsu M Hamasaki Y Tashiro K | 2000 | J Infect Dis2000，181，3： | 1 |
| 11 | Ulinastinin, elastase inhibitor, inhibits the increased mkNA expression of prostag]andin H2 synthase-type 2 in Kawasaki disease显示文摘 | Zaitsu M Hamasaki Y Tashiro K et M | 2000 | Journal of Infectious Diseases2000，181，3： | 1 |
| 12 | Ulinastatin,an elastase inhibitor,inhibits the increased mRNA expression of prostaglandin H2 synthase-type 2 in Kawasaki disease显示文摘 | Zaitsu M Hamasaki Y Tashiro K | | 0，，03： | 1 |
| 13 | New fluorogenic suhstmtes for horseraclish peroxidase: rapid and sensitive assays for hydrogen peroxide and the peroxidase显示文摘 | Zaitsu K and Ohkura Y | 1980 | Anal Biochem1980，109，： | 1 |
| 14 | Ulinastatin, an dastase inhibitor, inhibits the increased mRNA expression of prostaglandin H2 synthase-type 2 in Kawasaki disease显示文摘 | Zaitsu M Hamasaki Y Tashiro K | 2000 | J Infect Dis2000，181，3： | 1 |
| 15 | Ulinastatin, an elastase inhibitor, inhibits the increased mRNA expression of prostaglandin H2 synthase -type 2 in Kawasaki disease显示文摘 | Zaitsu M Hamasaki Y Tashiro K | 2000 | J Infect Dis2000，181，3： | 1 |
| 16 | Ulinastatin,an elastase inhibitor,inhibits the increased mRNA expression of prostaglandin H2 synthase-type 2 in Kawasaki disease显示文摘 | Zaitsu M Hamasaki Y Tashiro K | | 0，，03： | 1 |
| 17 | Induction of thromboxane A2 synthesizing enzymes in DMSO-induced granulocytic differentiation of HL-60 cells显示文摘 | ZAITSU M ISHII E HAMASAKI Y | 2002 | Prostag Leukot Essent Fatty Acids2002，67，6： | 1 |
| 18 | Fluorometric determination of aronlaticaldehydes with 1,2-diaminonaphthalene显示文摘 | Ohkura Y Zaitsu K | 1974 | Talanta1974，21，6： | 1 |
| 19 | Leukotriene synthesis isincreased by transcriptional up-regulation of 5-1ipoxygenase,leu- kotriene A4 hydrolase,and leukotriene C4 synthase in asthmatic children显示文摘 | Zaitsu M Hamasaki Y Matsuo M | 2003 | Asthma2003，40，2： | 1 |
| 20 | Mutual telexistence system using retro-reflective projection technology显示文摘 | TACHI S KAWAKAMI N INAMI M ZAITSU Y | 2004 | International Journal of Humanoid Robotics2004，1，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员